Pages that link to "Q69944532"
Jump to navigation
Jump to search
The following pages link to Lipoprotein and apolipoprotein losses during continuous ambulatory peritoneal dialysis (Q69944532):
Displaying 11 items.
- Proteomics analysis of the peritoneal dialysate effluent reveals the presence of calcium-regulation proteins and acute inflammatory response (Q33616578) (← links)
- Physical activity and blood lipids and lipoproteins in dialysis patients (Q36279707) (← links)
- Lipid abnormalities in renal disease (Q37660663) (← links)
- Disturbances of lipid metabolism in children with chronic renal failure (Q40725852) (← links)
- The uremic dyslipidemia: a cross-sectional and longitudinal study (Q50541682) (← links)
- Impaired metabolism of high density lipoprotein in uremic patients (Q68013716) (← links)
- Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels (Q68729384) (← links)
- The relationship between plasma and dialysate lipoproteins and apoproteins in patients treated by continuous ambulatory peritoneal dialysis (Q72630924) (← links)
- Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus (Q72664905) (← links)
- Hypertriglyceridemia and lowered apolipoprotein C-II/C-III ratio in uremia: effect of a fibric acid, clinofibrate (Q72758268) (← links)
- Lipoprotein(a) in patients treated by continuous ambulatory peritoneal dialysis (Q72809757) (← links)